公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | ALK resistance mutations and efficacy of lorlatinib in advanced anaplastic lymphoma kinase-positive non–small-cell lung cancer | Shaw A.T.; Solomon B.J.; Besse B.; Bauer T.M.; CHIA-CHI LIN ; Soo R.A.; Riely G.J.; Ignatius Ou S.-H.; Clancy J.S.; Li S.; Abbattista A.; Thurm H.; Satouchi M.; Camidge D.R.; Kao S.; Chiari R.; Gadgeel S.M.; Felip E.; Martini J.-F. | Journal of Clinical Oncology | 284 | 208 | |
2015 | An appendectomy increases the risk of rheumatoid arthritis: A five-year follow-up study | Tzeng Y.-M.; Kao L.-T.; Kao S.; Lin H.-C.; Tsai M.-C.; Lee, Cha-Ze | PLoS ONE | 22 | 19 | |
2015 | Benign prostatic enlargement is not associated with diabetes: A population-based study | Chiu Y.L.; Kao S.; Lin H.C.; SHIH-PING LIU ; CHAO-YUAN HUANG | Andrology | 8 | 7 | |
2016 | Healthcare service utilization for practicing physicians: A population-based study | Chiu Y.-L.; Kao S.; Lin H.-C.; Tsai M.-C.; Lee, Cha-Ze | PLoS ONE | 5 | 3 | |
2020 | Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer | Peters S.; Shaw A.T.; Besse B.; Felip E.; Solomon B.J.; Soo R.A.; Bearz A.; Gadgeel S.M.; CHIA-CHI LIN ; Kao S.; Seto T.; Masters E.T.; Abbattista A.; Clancy J.S.; Thurm H.; Reisman A.; Peltz G.; Ross Camidge D. | Lung Cancer | 14 | 12 | |
2019 | Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial | Shaw A.T.; Solomon B.J.; Chiari R.; Riely G.J.; Besse B.; Soo R.A.; Kao S.; CHIA-CHI LIN ; Bauer T.M.; Clancy J.S.; Thurm H.; Martini J.-F.; Peltz G.; Abbattista A.; Li S.; Ou S.-H.I. | The Lancet Oncology | 234 | 173 |